Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 44 citing articles:

Understanding the molecular mechanisms of statin pleiotropic effects
Charles German, James K. Liao
Archives of Toxicology (2023) Vol. 97, Iss. 6, pp. 1529-1545
Open Access | Times Cited: 55
Therapeutic monoclonal antibodies for COVID-19 management: an update
Vivek P. Chavda, Riddhi Prajapati, Disha Lathigara, et al.
Expert Opinion on Biological Therapy (2022) Vol. 22, Iss. 6, pp. 763-780
Closed Access | Times Cited: 51
Statin Use in COVID-19 Hospitalized Patients and Outcomes: A Retrospective Study
Hamideh Kouhpeikar, Hamidreza Khosaravizade Tabasi, Zahra Khazir, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 45
Statins—From Fungi to Pharmacy
Anna Sadowska, Patryk Osiński, Alicja Roztocka, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 466-466
Open Access | Times Cited: 21
Effectiveness of Drug Repurposing and Natural Products Against SARS-CoV-2: A Comprehensive Review
Paula Andrea Cuartas Velásquez, Juan C. Hernández, Elkin Galeano, et al.
Clinical Pharmacology Advances and Applications (2024) Vol. Volume 16, pp. 1-25
Open Access | Times Cited: 10
Lipid rafts as viral entry routes and immune platforms: A double-edged sword in SARS-CoV-2 infection?
Rossana Roncato, Jacopo Angelini, Arianna Pani, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2022) Vol. 1867, Iss. 6, pp. 159140-159140
Open Access | Times Cited: 30
Pathophysiology, diagnosis, and management of neuroinflammation in covid-19
Rachel Brown, Laura Benjamin, Michael P. Lunn, et al.
BMJ (2023), pp. e073923-e073923
Open Access | Times Cited: 20
Association of Statins for Primary Prevention of Cardiovascular Diseases With Hospitalization for COVID‐19: A Nationwide Matched Population‐Based Cohort Study
Kim Bouillon, Bérangère Baricault, Laura Semenzato, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 12
Open Access | Times Cited: 19
Systematic Review and Meta-Analysis of Statin Use and Mortality, Intensive Care Unit Admission and Requirement for Mechanical Ventilation in COVID-19 Patients
Ut-Sam Lao, Chak-Fun Law, Daniel T. Baptista‐Hon, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 18, pp. 5454-5454
Open Access | Times Cited: 19
Risk factors for COVID-19 case fatality rate in people with type 1 and type 2 diabetes mellitus: A nationwide retrospective cohort study of 235,248 patients in the Russian Federation
Marina V. Shestakova, O. K. Vikulova, A. R. Elfimova, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 18
Diabetes, COVID‐19, and questions unsolved
F. D'Souza, Raffaella Buzzetti, Paolo Pozzilli
Diabetes/Metabolism Research and Reviews (2023) Vol. 39, Iss. 5
Open Access | Times Cited: 8
Impact of P-selectin–PSGL-1 Axis on Platelet-Endothelium-Leukocyte Interactions in Fatal COVID-19
Massimo Granai, Verena Warm, Antonio Vogelsberg, et al.
Laboratory Investigation (2023) Vol. 103, Iss. 8, pp. 100179-100179
Open Access | Times Cited: 7
Efficacy of Statin Therapy in Patients with Hospital Admission for COVID-19
Daein Choi, Qinzhong Chen, Sascha N. Goonewardena, et al.
Cardiovascular Drugs and Therapy (2021) Vol. 36, Iss. 6, pp. 1165-1173
Open Access | Times Cited: 17
Treatment mechanism of immune triad from the repurposing drug against COVID-19
Jong‐Hoon Lee
Translational Medicine of Aging (2023) Vol. 7, pp. 33-45
Open Access | Times Cited: 6
Accumulation of CD28null Senescent T-Cells Is Associated with Poorer Outcomes in COVID19 Patients
Mia J. Coleman, Kourtney M. Zimmerly, Xuexian O. Yang
Biomolecules (2021) Vol. 11, Iss. 10, pp. 1425-1425
Open Access | Times Cited: 14
The importance of neopterin in COVID-19: The prognostic value and relation with the disease severity
Yousef Rasmi, Nadia Heidari, Kevser Kübra Kırboğa, et al.
Clinical Biochemistry (2022) Vol. 104, pp. 1-12
Open Access | Times Cited: 9
The association between statin and COVID-19 adverse outcomes: national COVID-19 cohort in South Korea
Ronald Chow, Jihui Lee, Hyerim Noh, et al.
Annals of Palliative Medicine (2022) Vol. 11, Iss. 4, pp. 1297-1307
Open Access | Times Cited: 9
Statins and Risk of Thrombosis in Critically ill Patients with COVID-19: A Multicenter Cohort Study
Shmeylan Al Harbi, Raed Kensara, Ohoud Aljuhani, et al.
Clinical and Applied Thrombosis/Hemostasis (2022) Vol. 28
Open Access | Times Cited: 9
Impact of Statin or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker on In-Hospital Mortality of COVID-19 Patients
Mohsen Gholinataj Jelodar, Samaneh Mirzaei, Majid Haji Maghsoudi
Journal of Pharmaceutical Care (2024)
Open Access | Times Cited: 1
Could Statin Therapy Be Useful in Patients With Coronavirus Disease 2019 (COVID-19)?
José D. Torres‐Peña, Niki Katsiki, Pablo Pérez‐Martínez
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 12
Treating COVID-19: Targeting the Host Response, Not the Virus
David S. Fedson
Life (2023) Vol. 13, Iss. 3, pp. 712-712
Open Access | Times Cited: 4
RAAS-Hemmung und darüber hinaus – Herz-Kreislauf-Medikation bei Patienten mit einem Risiko für oder Erkrankung durch COVID-19
Alexander Dutsch, Heribert Schunkert
Herz (2023) Vol. 48, Iss. 3, pp. 206-211
Open Access | Times Cited: 4
Associations of statin use with 30-day adverse outcomes among 4 801 406 US Veterans with and without SARS-CoV-2: an observational cohort study
Pandora L. Wander, Elliott Lowy, Lauren A. Beste, et al.
BMJ Open (2022) Vol. 12, Iss. 3, pp. e058363-e058363
Open Access | Times Cited: 7
American Heart Association Precision Medicine Platform Addresses Challenges in Data Sharing
Laura Stevens, James A. de Lemos, Sandeep R. Das, et al.
Circulation Cardiovascular Quality and Outcomes (2021) Vol. 14, Iss. 9
Open Access | Times Cited: 10
Clinical Characteristics and Outcomes among Vaccinated and Unvaccinated Patients with Cardiovascular Disease Who Were Hospitalized for COVID-19 in Brazil: Retrospective Cohort
Daniele Melo Sardinha, Ana Lúcia da Silva Ferreira, Ricardo José de Paula Souza e Guimarães, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 861-861
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top